Search

Avita Therapeutics Inc

Cerrado

15.32 -1.35

Resumen

Variación precio

24h

Actual

Mínimo

15.25

Máximo

15.65

Métricas clave

By Trading Economics

Ingresos

2.9M

-7.7M

Ventas

2.5M

22M

BPA

-0.25

Margen de beneficios

-35.31

Empleados

226

EBITDA

3M

-5.6M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

-12.67% downside

Dividendos

By Acuity

Próximas Ganancias

5 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

327M

469M

Apertura anterior

16.67

Cierre anterior

15.32

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 nov 2026, 23:51 UTC

South Korea's October Manufacturing PMI Release on November 2 Expected to Reflect Mixed Sentiment Amid Global Economic Pressures.

1 nov 2026, 23:51 UTC

Australia's Building Permits MoM data for September 2026 expected to rise by 2.1% amid cautious market sentiment and ongoing economic pressures.

1 nov 2026, 23:51 UTC

Upcoming ISM Manufacturing Employment Report on November 2, 2026, Expected to Reflect Cautious Sentiment Amid Global Economic Uncertainties.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Gold prices are advancing, supported by rising crude oil prices and increased investor interest in safe-haven assets amid geopolitical tensions in the Middle East.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Silver prices are advancing amid rising crude oil prices and geopolitical tensions, as investors seek safe-haven assets in response to global equity market declines.

1 nov 2026, 23:11 UTC

Brazil's Industrial Production Expected to Decline by 0.2% in September Amid Economic Concerns

1 nov 2026, 23:11 UTC

Australia's Balance of Trade Expected to Show AUD 1.2 Billion Surplus for September Amid Global Economic Uncertainties

1 nov 2026, 23:11 UTC

Macro News

The Dow Jones Industrial Average is advancing today, recovering from Friday's selloff amid geopolitical tensions and rising oil prices, despite earlier session pullbacks.

1 nov 2026, 23:11 UTC

Macro News

The S&P 500 Index is modestly higher despite significant declines in global equity markets and rising oil prices amid geopolitical tensions in the Middle East.

1 nov 2026, 23:11 UTC

Macro News

Natural gas prices are advancing sharply amid rising crude oil prices and fears of supply disruptions linked to ongoing conflicts involving Iran.

1 nov 2026, 23:11 UTC

The EUR/JPY is trading higher at the start of the new week, despite broader market apprehension following a significant U.S. stock selloff on Friday.

1 nov 2026, 23:11 UTC

Macro News
Correlated Moves

Platinum is trading modestly higher as crude oil prices surge amid supply disruption fears linked to ongoing conflicts in the Middle East.

1 nov 2026, 23:11 UTC

Macro News

The Nasdaq 100 Index is advancing, showing a modest increase despite significant declines in global equity markets amid rising oil prices and geopolitical tensions.

1 nov 2026, 23:11 UTC

Macro News

The Russell 2000 Index is modestly higher, gaining ground despite significant declines in major U.S. indices amid rising oil prices and geopolitical tensions.

1 nov 2026, 23:01 UTC

Macro News

The Australian dollar is under pressure amid rising fuel prices and potential $700 million losses at Alaska Air, showing weakness in early trading.

1 nov 2026, 23:01 UTC

The GBP/AUD is advancing as the new trading week begins, showing resilience amid recent volatility in U.S. equity markets.

1 nov 2026, 23:01 UTC

The EUR/AUD is advancing in early trading as the new week begins, following a flat performance since Friday's close.

1 nov 2026, 23:01 UTC

The EUR/CZK is advancing in early trading, showing a slight uptick since Friday's close amid a cautious investor outlook following U.S. market volatility.

1 nov 2026, 23:01 UTC

The EUR/PLN is advancing in early trading this week, positioned near the upper end of its one-month range amid broader market volatility.

1 nov 2026, 22:51 UTC

UK MPC Meeting Minutes on November 5, 2026: Investors Brace for Insights on Interest Rate Changes Amid Rising Inflation and Geopolitical Tensions.

1 nov 2026, 22:31 UTC

Mexican Consumer Confidence Index Set for November 4 Release Amid Ongoing Economic Concerns and Weak Sentiment.

1 nov 2026, 22:11 UTC

Mexico's Business Confidence Data Release on November 3, 2026 Expected to Show Continued Pessimism Amidst Stagnant Manufacturing Trends.

1 nov 2026, 22:11 UTC

Brazil's Central Bank to announce interest rate decisions on November 3, 2026, amid cautious economic sentiment and inflation concerns.

1 nov 2026, 22:01 UTC

Mortgage Rates Decline to 7.37%, Offering Hope for Homebuyers Amid High Prices and Cautious Market Sentiment Ahead of November Data Release

1 nov 2026, 21:41 UTC

Turkey's Balance of Trade Data Release on November 4 Expected to Highlight Ongoing Trade Deficit Amid Economic Optimism and Geopolitical Tensions.

1 nov 2026, 21:41 UTC

Australia's Ai Group Industry Index set for release on November 3 amid cautious market expectations following a significant decline and ongoing investor concerns in the tech sector.

1 nov 2026, 21:31 UTC

Euro Area Retail Sales Expected to Decline by 0.1% Amid Economic Uncertainty and Rising Inflation, with Implications for GDP Growth and Monetary Policy

1 nov 2026, 21:31 UTC

France's Industrial Production MoM data for September 2026 set to release on November 5, with a cautious market anticipating only a modest increase of 0.5% amid rising borrowing costs and negative fiscal outlook.

1 nov 2026, 21:31 UTC

France's Trade Deficit Expected at €5.8 Billion Amid Negative Outlook and Economic Concerns Ahead of November 6 Report

1 nov 2026, 21:31 UTC

Italy's Retail Sales MoM report on November 5 forecasts a modest 0.2% increase amid fluctuating consumer spending trends and inflationary pressures.

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

-12.67% descenso

Estimación a 12 Meses

Media 13.667 USD  -12.67%

Máximo 15 USD

Mínimo 12 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat